- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/18 - Drugs for disorders of the endocrine system of the parathyroid hormones
Patent holdings for IPC class A61P 5/18
Total number of patents in this class: 157
10-year publication summary
|
7
|
7
|
17
|
12
|
8
|
9
|
9
|
12
|
19
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ascendis Pharma Bone Diseases A/S | 56 |
23 |
| Daiichi Sankyo Company, Limited | 1890 |
8 |
| Entera Bio Ltd. | 50 |
8 |
| Amgen Inc. | 4467 |
6 |
| Asahi Kasei Pharma Corporation | 115 |
5 |
| Wisconsin Alumni Research Foundation | 3903 |
4 |
| Takeda Pharmaceutical Company Limited | 2700 |
4 |
| EA Pharma Co., Ltd. | 97 |
4 |
| EirGen Pharma Limited | 90 |
4 |
| Xeris Pharmaceuticals, Inc. | 115 |
4 |
| LEO Pharma A/S | 448 |
4 |
| Vertex Pharmaceuticals Incorporated | 1577 |
3 |
| Chugai Seiyaku Kabushiki Kaisha | 1426 |
3 |
| Kyowa Hakko Kirin Co., Ltd. | 262 |
3 |
| Lupin Limited | 445 |
3 |
| Mironid Limited | 23 |
3 |
| The General Hospital Corporation | 4890 |
2 |
| Ajinomoto Co., Inc. | 2284 |
2 |
| Dainippon Sumitomo Pharma Co., Ltd. | 163 |
2 |
| Dongguk University Industry-Academic Cooperation Foundation | 482 |
2 |
| Other owners | 60 |